Evaluation in mice of the immunogenicity and protective efficacy of a tetravalent subunit vaccine candidate against dengue virus.
about
Neutralizing Antibody Response and Efficacy of Novel Recombinant Tetravalent Dengue DNA Vaccine Comprising Envelope Domain III in Mice.A novel dengue virus serotype 1 vaccine candidate based on Japanese encephalitis virus vaccine strain SA14-14-2 as the backbone.A novel tetravalent formulation combining the four aggregated domain III-capsid proteins from dengue viruses induces a functional immune response in mice and monkeys.A Natural Mouse Model for Neisseria Colonization.Recent Developments in Recombinant Protein-Based Dengue Vaccines
P2860
Evaluation in mice of the immunogenicity and protective efficacy of a tetravalent subunit vaccine candidate against dengue virus.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Evaluation in mice of the immu ...... andidate against dengue virus.
@en
type
label
Evaluation in mice of the immu ...... andidate against dengue virus.
@en
prefLabel
Evaluation in mice of the immu ...... andidate against dengue virus.
@en
P2093
P2860
P356
P1476
Evaluation in mice of the immu ...... andidate against dengue virus.
@en
P2093
Alienys Izquierdo
Edith Suzarte
Ernesto Marcos
Gerardo Guillén
Iris Valdés
Laura Lazo
Lisset Hermida Cruz
Lázaro Gil
María Guadalupe Guzmán
Mayling Álvarez
P2860
P304
P356
10.1111/1348-0421.12140
P577
2014-04-01T00:00:00Z